Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balakrishna Hosmane

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|June 22, 2013
Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studiesZhiwu Yan, Balakrishna Hosmane, Charles Locke
Journal of Biopharmaceutical Statistics|June 22, 2013
The joint modeling of drug and positive control effects to estimate sample size and power in crossover "thorough" QT/QTc studiesBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Biopharmaceutical Statistics|April 2, 2010
Sample size and power estimation in "thorough" QT/QTc studies with parallel group designBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Biopharmaceutical Statistics|April 2, 2010
Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studiesBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Sex & Marital Therapy|January 12, 2010
Randomized, placebo-controlled, double-blind, parallel design trial of the efficacy and safety of Zestra in women with mixed desire/interest/arousal/orgasm disordersDavid M Ferguson, Balakrishna Hosmane, Julia R Heiman
Journal of Biopharmaceutical Statistics|July 5, 2021
Drug response hysteresis in the concentration-QTc analysis of early clinical trialsHong Li, Bo Tong, Balakrishna Hosmane, et al.
Journal of Biopharmaceutical Statistics|November 19, 2025
Blinded sample size re-estimation in a crossover studyShaofei Zhao, Balakrishna Hosmane, Chen Chen, et al.
Clinical Pharmacology and Therapeutics|August 2, 2017
Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay SensitivityMohamed-Eslam F Mohamed, Jiewei Zeng, Ping Jiang, et al.
Journal of Medicinal Chemistry|June 21, 2021
Global Analysis of Models for Predicting Human Absorption: QSAR, <i>In Vitro</i>, and Preclinical ModelsEdward Price, J Cory Kalvass, David DeGoey, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2013
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumorsYi-Lin Chiu, Patricia Lorusso, Balakrishna Hosmane, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|June 22, 2013
Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studiesZhiwu Yan, Balakrishna Hosmane, Charles Locke
Journal of Biopharmaceutical Statistics|June 22, 2013
The joint modeling of drug and positive control effects to estimate sample size and power in crossover "thorough" QT/QTc studiesBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Biopharmaceutical Statistics|April 2, 2010
Sample size and power estimation in "thorough" QT/QTc studies with parallel group designBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Biopharmaceutical Statistics|April 2, 2010
Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studiesBalakrishna Hosmane, Charles Locke, Yi-Lin Chiu
Journal of Sex & Marital Therapy|January 12, 2010
Randomized, placebo-controlled, double-blind, parallel design trial of the efficacy and safety of Zestra in women with mixed desire/interest/arousal/orgasm disordersDavid M Ferguson, Balakrishna Hosmane, Julia R Heiman
Journal of Biopharmaceutical Statistics|July 5, 2021
Drug response hysteresis in the concentration-QTc analysis of early clinical trialsHong Li, Bo Tong, Balakrishna Hosmane, et al.
Journal of Biopharmaceutical Statistics|November 19, 2025
Blinded sample size re-estimation in a crossover studyShaofei Zhao, Balakrishna Hosmane, Chen Chen, et al.
Clinical Pharmacology and Therapeutics|August 2, 2017
Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay SensitivityMohamed-Eslam F Mohamed, Jiewei Zeng, Ping Jiang, et al.
Journal of Medicinal Chemistry|June 21, 2021
Global Analysis of Models for Predicting Human Absorption: QSAR, <i>In Vitro</i>, and Preclinical ModelsEdward Price, J Cory Kalvass, David DeGoey, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2013
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumorsYi-Lin Chiu, Patricia Lorusso, Balakrishna Hosmane, et al.
Pageof 2